Furthermore, Huang et al. [95] demonstrated for the first time that the ERK1/2-Nanog signalling pathway played a critical role in the maintenance of cells stemness and tumourigenic abilities by enhancing CD44+ CSCs in head and neck squamous cell carcinomas. Here, CD44 is linked to head and neck squamous cell carcinoma.